These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37827233)

  • 1. TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson' disease mice.
    He Y; Zhao J; Dong H; Zhang X; Duan Y; Ma Y; Yu M; Fei J; Huang F
    Life Sci; 2023 Nov; 333():122171. PubMed ID: 37827233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
    Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
    Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
    Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
    J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imperatorin inhibits oxidative stress injury and neuroinflammation via the PI3K/AKT signaling pathway in the MPTP-induced Parkinson's disease mouse.
    Liu L; Jiang L; Zhang J; Ma Y; Wan M; Hu X; Yang L
    Neuroreport; 2024 Feb; 35(3):175-184. PubMed ID: 38305108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axis
    Gui J; Sun X; Wen S; Liu X; Qin B; Sang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):270-279. PubMed ID: 38501412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.
    Drouin-Ouellet J; Gibrat C; Bousquet M; Calon F; Kriz J; Cicchetti F
    J Neuroinflammation; 2011 Oct; 8():137. PubMed ID: 21989292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson's disease by inhibiting oxidative stress and neuroinflammation.
    Chen M; He X; Fan Y; Xia L; Dong Z
    Mol Biol Rep; 2024 Aug; 51(1):908. PubMed ID: 39141244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic Acid Rescues Dopaminergic Neurons in MPTP-Induced Mice by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
    Jia Y; Li J; Wang Y; Ma Y; Chen L; Zhang H; Xue M; Liang H
    J Agric Food Chem; 2024 Mar; 72(11):5734-5745. PubMed ID: 38453725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
    Meng T; Zhang Y; Huang J; Pandey V; Fu S; Ma S
    Phytomedicine; 2024 Feb; 124():155309. PubMed ID: 38237261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.
    Cheng YY; Chen BY; Bian GL; Ding YX; Chen LW
    Mol Neurobiol; 2022 Apr; 59(4):2642-2655. PubMed ID: 35142987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.
    Hwang CJ; Choi DY; Jung YY; Lee YJ; Yun JS; Oh KW; Han SB; Oh S; Park MH; Hong JT
    Horm Behav; 2016 Apr; 80():19-29. PubMed ID: 26836768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of neuroinflammation and α-synuclein oligomerization by rotarod walking exercise in subacute MPTP model of Parkinson's disease.
    Leem YH; Park JS; Park JE; Kim DY; Kim HS
    Neurochem Int; 2023 May; 165():105519. PubMed ID: 36931345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
    Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
    Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
    Kartik S; Pal R; Chaudhary MJ; Nath R; Kumar M; Binwal M; Bawankule DU
    Inflammopharmacology; 2023 Apr; 31(2):927-941. PubMed ID: 36715843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.